A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of AT-752, a Novel Nucleotide Prodrug with Pan-Serotype Activity, in Adult Patients with Dengue Virus Infection

AT-752 - Atea Pharma

https://plan.core-apps.com/astmh23/abstract/5cf1a94a-7802-4b3e-b9e0-cfc4c606b7f2

Arantxa Horga1; Mauro M. Teixiera2; Swapnav Borthakur3; Richa Giri4; Shannan Lynch1; Janice Chin1; Laura Ishak1; Xiao-Jian Zhou1; Keith Pietropaolo1; Bruce Belanger1; Yang Lei1; Qi Huang1; Janet Hammond1

Oct 11, 2023